Eurofins Healthcare Assurance expands GMP certification scopes

In a June 10, press release, the Eurofins Healthcare Assurance network announced four new GMP certification scope programs to help buyers and suppliers achieve U.S. Food and Drug Administration (FDA) compliance for dietary ingredients, cosmetics, and over-the-counter drugs. The growth of certain sectors in the US was noted in the press release for the following areas:

• ISO 22716:2007 – Good Manufacturing Practices for Cosmetics

• NSF/ANSI 455-3 – 2024 – Good Manufacturing Practices for Cosmetics

• NSF/ANSI 455-4 – 2024 – Good Manufacturing Practices for Over-the Counter Drugs

• 21 CFR 111/117, NSF/ANSI 173, Section 8 – 2024 for Dietary Ingredients

The process includes an on-site audit that evaluates product categories and manufacturing processes and an assessment of quality management systems, with any issues resolved before the certification is presented. Monitoring and recertification follow after the initial Eurofins Healthcare Assurance GMP certification, along with permission to use Eurofins Certification marks.

In January 2025, Eurofins Healthcare Assurance had announced¹ a new GMP certification program for dietary and food supplements, covering 21 CFR 111/117 and NSF/ANSI 455-2-2024 standards and intended for manufacturers, brands, agents, and retailers achieve compliance.

The Eurofins network extends across Asia, Africa, Europe and South America, supporting compliance and performance improvement to various industries.

References

1. McEvoy, E. Eurofins Healthcare Assurance offers new GMP certification program for dietary and food supplements https://www.nutritionaloutlook.com/view/eurofins-healthcare-assurance-offers-new-gmp-certification-program-for-dietary-and-food-supplements (accessed 2025-06-10).